Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Janvier 2023 - 10:01PM
Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the
Company), a women's health company focused on the treatment of
Abnormal Uterine Bleeding (AUB), announced today that its
management team will present at the 41st Annual J.P. Morgan
Healthcare Conference on Thursday, January 12th at 9:45 a.m.
Pacific Time.
A live audio webcast and replay of the presentation may be
accessed through the “Recent Events” section of Minerva’s website
at http://ir.minervasurgical.com.
About Minerva Surgical, Inc.
Minerva Surgical is a commercial-stage medical technology
company focused on developing, manufacturing, and commercializing
minimally invasive solutions to meet the distinct uterine
healthcare needs of women. The Company has established a broad
product line of commercially available, minimally invasive
alternatives to hysterectomy, which are designed to address the
most common causes of Abnormal Uterine Bleeding (AUB) in most
uterine anatomies. The Minerva Surgical solutions can be used in a
variety of medical treatment settings and aim to address the
drawbacks associated with alternative treatment methods and to
preserve the uterus by avoiding unnecessary hysterectomies.
MEDIA CONTACT
Mike Clappermike.clapper@minervasurgical.com 804-295-7676
INVESTOR RELATIONS CONTACT
Caroline Cornerinvestors@minervasurgical.com415-202-5678
RELATED LINKS
https://www.aubandme.com
https://www.minervasurgical.com
Minerva Surgical (NASDAQ:UTRS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Minerva Surgical (NASDAQ:UTRS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024